Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

American Air sues Orbitz

By Aaron Smith, staff writer


NEW YORK (CNNMoney) -- American Airlines has filed an antitrust suit against Orbitz Worldwide and its parent, the latest salvo in a long-simmering dispute over online airfares.

The airline wants Travelport and Orbitz, (OWW) which is 48% owned by Travelport, to use its direct connect technology to access airfares online. The two companies use a different type of technology called global distribution system.

American, which is owned by AMR Corp (AMR, Fortune 500)., said it targeted Travelport because it "effectively controls the distribution of fares" and "has engaged in anticompetitive conduct to protect its market positions from new competition by alternative technologies that are both less expensive and capable."

But Orbitz spokesman Brian Hoyt accused American of using "schoolyard bullying tactics to try and force us into submission."

"They're trying to force a distribution deal with us that is ultimately a negative for consumers," said Hoyt.

Travelport said in a press release that the lawsuit is "merely another attempt by AA to gain bargaining leverage through litigation" and that it will defend itself in the suit, which was filed in the U.S. District Court for Northern Texas.

American and Orbitz used to be partners, but they parted ways in December.

At that time, American also broke up with Expedia, but they patched things up and resumed their partnership on April 5. To top of page

Search for Jobs

Index Last Change % Change
Dow 19,804.72 -22.05 -0.11%
Nasdaq 5,555.66 16.93 0.31%
S&P 500 2,271.89 4.00 0.18%
Treasuries 2.39 0.06 2.66%
Data as of 7:30pm ET
Company Price Change % Change
Bank of America Corp... 22.63 0.58 2.63%
Ford Motor Co 12.41 0.00 0.00%
Chesapeake Energy Co... 6.98 -0.03 -0.43%
Citigroup Inc 57.39 -0.99 -1.70%
Reynolds American In... 58.00 0.32 0.55%
Data as of 4:01pm ET
Sponsors

Sections

Irish drug maker Mallinckrodt will have to pay a $100 million fine and allow one of its competitors to produce a life-saving medication used to treat infants. The company hiked the price of the drug from $40 per vial to more than $34,000 per vial over the course of about 15 years. More

Federal Reserve Chair Janet Yellen gave her outlook on monetary policy days before Donald Trump becomes president. More

Navient, formerly part of Sallie Mae, was sued by the CFPB Wednesday for allegedly cheating borrowers out of repayment rights. More